Nxera Pharma Co Ltd (FRA:JSS)
€ 7.2 0.1 (1.41%) Market Cap: 660.35 Mil Enterprise Value: 783.12 Mil PE Ratio: 0 PB Ratio: 1.56 GF Score: 66/100

Sosei Group Corp to Acquire Idorsia Ltd Pharmaceuticals Business in Japan and APAC Transcript

Jul 20, 2023 / NTS GMT
Release Date Price: €8.9 (-3.78%)
Hironoshin Nomura
Sosei Group Corporation - Executive VP & CFO

[Interpreted] Ladies and gentlemen, since its time, about the acquisition of Idorsia Pharmaceuticals business in Japan and APAC, ex China, (inaudible). We would like to have a first conference. Despite such a short notice, we would like to thank you for coming, such a large turnout. I'm (inaudible) here at the venue. Not all of you are here, but more than 220 people are joining us on the web. So allow me to get started. Today, for 1 hour, 5 p.m. to 6 p.m., we'd like to have this meeting. Firstly from us, we would like to give the presentation. Here are the venue using the materials for the presentation, followed by the questions and answers. Time is limited, allow us to get started.

First, allow me to introduce today's speakers to your right. On left-hand side, that's Chris Cargill, the Sosei Group CEO; right next to him is Idorsia Pharmaceuticals' Jean-Paul, represented Director; President, Dr. Satoshi Tanaka. I am the CFO of the Sosei Group, Hironoshin Nishishita, our (inaudible) today. I'd like to invite Chris to talk about this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot